ArticleStatistics in medicine2017
A statistical framework for biomedical literature mining.
Article in Statistics in medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Sparse Linear Discriminant Analysis using the Prior-Knowledge-Guided Block Covariance Matrix.Chemometrics and intelligent laboratory systems : an international journal sponsored by the Chemometrics Society · 2020Article
- PALMER: improving pathway annotation based on the biomedical literature mining with a constrained latent block model.BMC bioinformatics · 2020Article
- DES-ROD: Exploring Literature to Develop New Links between RNA Oxidation and Human Diseases.Oxidative medicine and cellular longevity · 2020Article
- Literature-Based Enrichment Insights into Redox Control of Vascular Biology.Oxidative medicine and cellular longevity · 2019Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In systems biology, it is of great interest to identify new genes that were not previously reported to be associated with biological pathways related to various functions and diseases. Identification of these new pathway-modulating genes does not only promote understanding of pathway regulation mechanisms but also allow identification of novel targets for therapeutics. Recently, biomedical literature has been considered as a valuable resource to investigate pathway-modulating genes. While the majority of currently available approaches are based on the co-occurrence of genes within an abstract, it has been reported that these approaches show only sub-optimal performances because 70% of abstracts contain information only for a single gene. To overcome such limitation, we propose a novel statistical framework based on the concept of ontology fingerprint that uses gene ontology to extract information from large biomedical literature data. The proposed framework simultaneously identifies pathway-modulating genes and facilitates interpreting functions of these new genes. We also propose a computationally efficient posterior inference procedure based on Metropolis-Hastings within Gibbs sampler for parameter updates and the poor man's reversible jump Markov chain Monte Carlo approach for model selection. We evaluate the proposed statistical framework with simulation studies, experimental validation, and an application to studies of pathway-modulating genes in yeast. The R implementation of the proposed model is currently available at https://dongjunchung.github.io/bayesGO/. Copyright © 2017 John Wiley & Sons, Ltd.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.